{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T04:08:26Z","timestamp":1743221306245,"version":"3.40.3"},"reference-count":15,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_almed-2025-0003_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders characterized by peripheral blood cytopenias, cellular dysplasia and risk for progression into acute leukemia. Recent studies reveal that some research parameters available on Sysmex XN-1000<jats:sup>\u00ae<\/jats:sup> hematology analyzers, including immature platelet fraction (IPF), Neutrophil Granularity Index (Neu-GI), or platelet distribution width (PDW), show a relationship with dysplasia in peripheral blood. The objective of this study was to examine the association between classic and research blood count parameters and the presence of dysplasia. The\u00a0secondary objective was to develop a multivariate model that allows the prediction of dysplasia with high probability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_almed-2025-0003_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Seventy-five patients older than 60 years with anemia, leukopenia or thrombocytopenia, without vitamin B12 and folate deficiency or hematological diseases underwent testing with the Sysmex XN-1000 analyzer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_almed-2025-0003_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Dysplasia was confirmed in 32\u202f% of patients, with significant differences in Neu-GI, PDW and IPF count between the groups of patients with and without dysplasia. Neu-GI was the parameter with the highest predictive value (AUC=0.98), with such value not increasing significantly after the addition of PDW or PIF. A Neu-GI value\u2264146ch predicts dysplasia with a positive predictive value=90\u202f%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_almed-2025-0003_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Neu-GI is the parameter most strongly associated with dysplasia. A Neu-GI value\u2264146ch indicates a high probability of dysplasia and supports indication for a\u00a0blood smear review. Additionally, values&gt;152ch indicate a low probability of dysplasia.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/almed-2025-0003","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T15:10:28Z","timestamp":1738595428000},"page":"98-102","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the research parameters available on the Sysmex<sup>\u00ae<\/sup> XN-series hematology analyzers as markers of dysplasia in peripheral blood"],"prefix":"10.1515","volume":"6","author":[{"given":"Vicente","family":"Aguadero","sequence":"first","affiliation":[{"name":"Laboratory of Sant Joan Desp\u00ed Mois\u00e8s Broggi Hospital , Consorci del Laboratori Intercomarcal de l\u2019Alt Pened\u00e8s , l\u2019Anoia i el Garraf (CLILAB Diagn\u00f2stics) , Vilafranca del Pened\u00e8s , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Laboratory of Sant Joan Desp\u00ed Mois\u00e8s Broggi Hospital , Consorci del Laboratori Intercomarcal de l\u2019Alt Pened\u00e8s , l\u2019Anoia i el Garraf (CLILAB Diagn\u00f2stics) , Vilafranca del Pened\u00e8s , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00edriam","family":"Ru\u00edz","sequence":"additional","affiliation":[{"name":"Laboratoy of Vilafranca Del Pened\u00e8s , 504109 Consorci del Laboratori Intercomarcal de l\u2019Alt Pened\u00e8s, l\u2019Anoia i el Garraf (CLILAB Diagn\u00f2stics) , Vilafranca del Pened\u00e8s , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Regidor","sequence":"additional","affiliation":[{"name":"Laboratoy of Vilafranca Del Pened\u00e8s , 504109 Consorci del Laboratori Intercomarcal de l\u2019Alt Pened\u00e8s, l\u2019Anoia i el Garraf (CLILAB Diagn\u00f2stics) , Vilafranca del Pened\u00e8s , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Celma","sequence":"additional","affiliation":[{"name":"Laboratory of Sant Joan Desp\u00ed Mois\u00e8s Broggi Hospital , Consorci del Laboratori Intercomarcal de l\u2019Alt Pened\u00e8s , l\u2019Anoia i el Garraf (CLILAB Diagn\u00f2stics) , Vilafranca del Pened\u00e8s , Barcelona , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"2025032722230578904_j_almed-2025-0003_ref_001","doi-asserted-by":"crossref","unstructured":"Mufti, GJ, Bennett, J, Goasguen, J, Bain, BJ, Baumann, I, Brunning, R, et al.. International working group on morphology of myelodysplastic syndrome. diagnosis and classification of myelodysplastic syndrome: international working group on morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts. Haematologica 2008;93:1712\u20137. https:\/\/doi.org\/10.3324\/haematol.13405.","DOI":"10.3324\/haematol.13405"},{"key":"2025032722230578904_j_almed-2025-0003_ref_002","doi-asserted-by":"crossref","unstructured":"Mufti, GJ. Pathobiology, classification, and diagnosis of myelodysplastic syndrome. Best Pract Res Clin Haematol 2004;17:543\u201357. https:\/\/doi.org\/10.1016\/j.beha.2004.08.007.","DOI":"10.1016\/S1521-6926(04)00073-8"},{"key":"2025032722230578904_j_almed-2025-0003_ref_003","doi-asserted-by":"crossref","unstructured":"Fontana, D, Elli, EM, Pagni, F, Piazza, R. Myelodysplastic syndromes\/myeloproliferative overlap neoplasms and differential diagnosis in the WHO and ICC 2022 era: a focused review. Cancers 2023;15:3175. https:\/\/doi.org\/10.3390\/cancers15123175.","DOI":"10.3390\/cancers15123175"},{"key":"2025032722230578904_j_almed-2025-0003_ref_004","unstructured":"S\u00e1nchez, J, Serrano, J, Garc\u00eda, JM, Torres, A. S\u00edndromes mielodispl\u00e1sicos. Medicine 2008;10:1402\u20138."},{"key":"2025032722230578904_j_almed-2025-0003_ref_005","doi-asserted-by":"crossref","unstructured":"Kwiecie\u0144, I, Rutkowska, E, Gawro\u0144ski, K, Kulik, K, Dudzik, A, Zakrzewska, A, et al.. Usefulness of new neutrophil-related hematologic parameters in patients with myelodysplastic syndrome. Cancers (Basel) 2023;15:2488. https:\/\/doi.org\/10.3390\/cancers15092488.","DOI":"10.3390\/cancers15092488"},{"key":"2025032722230578904_j_almed-2025-0003_ref_006","doi-asserted-by":"crossref","unstructured":"Zimmermann, M, Steenhuis, P, Linssen, J, Weimann, A. Detection and quantification of hypo- and hypergranulated neutrophils on the new Sysmex XN hematology analyzer: establishment of an adapted reference interval for the neutrophil-granularity-intensity compared to XE-technology in adult patients. Clin Lab 2015;61:235\u201341. https:\/\/doi.org\/10.7754\/clin.lab.2014.140704.","DOI":"10.7754\/Clin.Lab.2014.140704"},{"key":"2025032722230578904_j_almed-2025-0003_ref_007","doi-asserted-by":"crossref","unstructured":"Saigo, K, Takenokuchi, M, Imai, J, Numata, K, Isono, S, Zenibayashi, M, et al.. Usefulness of immature platelet fraction for the clinical evaluation of myelodysplastic syndromes. Lab Hematol 2009;15:13\u20136. https:\/\/doi.org\/10.1532\/lh96.09003.","DOI":"10.1532\/LH96.09003"},{"key":"2025032722230578904_j_almed-2025-0003_ref_008","unstructured":"Merino, A. Manual de Citolog\u00eda de Sangre Perif\u00e9rica y L\u00edquidos Biol\u00f3gicos, 2nd ed. M\u00e9dica Panamericana, vol.\u00a06; 2020:121\u201335 pp."},{"key":"2025032722230578904_j_almed-2025-0003_ref_009","doi-asserted-by":"crossref","unstructured":"Kowalska-K\u0119pczy\u0144ska, A, Mleczko, M, Domerecka, W, Krasowska, D, Donica, H. Assessment of immune cell activation in pemphigus. Cells 2022;11:1912, https:\/\/doi.org\/10.3390\/cells11121912.","DOI":"10.3390\/cells11121912"},{"key":"2025032722230578904_j_almed-2025-0003_ref_010","doi-asserted-by":"crossref","unstructured":"Furundarena, JR, Araiz, M, Uranga, M, Sainz, MR, Agirre, A, Trassorras, M, et al.. The utility of the Sysmex XE-2100 analyzer\u2019s NEUT-X and NEUT-Y parameters for detecting neutrophil dysplasia\u00a0in myelodysplastic syndromes. Int J Lit Humanit 2010;32:360\u20136. https:\/\/doi.org\/10.1111\/j.1751-553x.2009.01194.x.","DOI":"10.1111\/j.1751-553X.2009.01194.x"},{"key":"2025032722230578904_j_almed-2025-0003_ref_011","doi-asserted-by":"crossref","unstructured":"Boutault, R, Peterlin, P, Boubaya, M, Sockel, K, Chevallier, P, Garnier, A, et al.. A novel complete blood count-based score to screen for myelodysplastic syndrome in cytopenic patients. Br J Haematol 2018;183:736\u201346. https:\/\/doi.org\/10.1111\/bjh.15626.","DOI":"10.1111\/bjh.15626"},{"key":"2025032722230578904_j_almed-2025-0003_ref_012","doi-asserted-by":"crossref","unstructured":"Zhu, Y, Han, S, Chen, X, Wu, S, Xiong, B. Improving the diagnosis of myelodysplastic syndrome by red blood cell parameters. Clin Transl Oncol 2023;25:2983\u201390. https:\/\/doi.org\/10.1007\/s12094-023-03166-w.","DOI":"10.1007\/s12094-023-03166-w"},{"key":"2025032722230578904_j_almed-2025-0003_ref_013","unstructured":"Liang, HP, Wang, Y, Li, D, Zhang, LL, Wu, C, Ren, JH. The diagnostic value of peripheral blood cell parameters for early recognition of myelodysplastic syndrome. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2021;29:1231\u20135. https:\/\/doi.org\/10.19746\/j.cnki.issn.1009-2137.2021.04.032."},{"key":"2025032722230578904_j_almed-2025-0003_ref_014","doi-asserted-by":"crossref","unstructured":"Chandrashekar, V, Tarigopula, A. Can platelet distribution width Be used to predict the possibility of chronic myeloproliferative neoplasms? Lab Med 2019;50:174\u20139. https:\/\/doi.org\/10.1093\/labmed\/lmy061.","DOI":"10.1093\/labmed\/lmy061"},{"key":"2025032722230578904_j_almed-2025-0003_ref_015","doi-asserted-by":"crossref","unstructured":"Larruzea, A, Mu\u00f1oz, L, Perea, G, Torra, M. Evaluation of immature platelet fraction in patients with myelodysplastic syndromes. Association with poor prognosis factors. Clin Chem Lab Med 2019;57:e128\u201330. https:\/\/doi.org\/10.1515\/cclm-2018-0784.","DOI":"10.1515\/cclm-2018-0784"}],"container-title":["Advances in Laboratory Medicine \/ Avances en Medicina de Laboratorio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/almed-2025-0003\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/almed-2025-0003\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T08:42:39Z","timestamp":1743151359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/almed-2025-0003\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,2]]},"published-print":{"date-parts":[[2025,3,28]]}},"alternative-id":["10.1515\/almed-2025-0003"],"URL":"https:\/\/doi.org\/10.1515\/almed-2025-0003","relation":{},"ISSN":["2628-491X"],"issn-type":[{"type":"electronic","value":"2628-491X"}],"subject":[],"published":{"date-parts":[[2025,2,4]]}}}